Optimal duration of dual antiplatelet therapy for coronary artery disease

The optimal duration of dual antiplatelet therapy (DAPT) for stable coronary artery disease and acute coronary syndrome is a complex decision. We review current literature on standard duration DAPT versus short duration DAPT (6 months or shorter) or extended duration DAPT (>12 months) after percu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kikkert, W. J., Damman, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968000/
https://www.ncbi.nlm.nih.gov/pubmed/29713989
http://dx.doi.org/10.1007/s12471-018-1113-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968000/
https://www.ncbi.nlm.nih.gov/pubmed/29713989
http://dx.doi.org/10.1007/s12471-018-1113-5

Ejemplares similares